Status:
COMPLETED
Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision
Lead Sponsor:
Bp Consulting, Inc
Conditions:
Myopia
Eligibility:
All Genders
21+ years
Phase:
PHASE4
Brief Summary
To evaluate the effect of PEG-400 and Systane on quality of vision after LASIK.
Eligibility Criteria
Inclusion
- Males or females \> 21 years old
- Scheduled to undergo bilateral LASIK
- Likely to complete all study visits and able to provide informed consent
Exclusion
- Prior or current use of topical cyclosporine within the last 1 year
- Known contraindications to any study medication or ingredients
- Ocular disorders
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies
- Complications at the time of surgery
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00627302
Start Date
February 1 2008
End Date
November 1 2008
Last Update
November 24 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Consultants of long Island
Rockville Centre, New York, United States, 11570